Scientists at the Royal Veterinary College, contributing to a programme to tackle some of the most harmful and widespread endemic diseases that commonly affect farmed animals in the UK, have developed a severity estimation calculator for post-weaning multi-systemic wasting syndrome (PMWS).

Post-weaning multi-systemic wasting syndrome (PMWS) is a common disease of young pigs in the U.K. It is extremely debilitating, causes considerable suffering and poor welfare, and has a high mortality of up to 30%. It is estimated that the disease costs the UK farming industry £30m per year.

The £2.4m project - headed by Professor Dirk Werling from the Royal Veterinary College and funded by the Biotechnology and Biological Sciences Research Council (BBSRC) through its "Combating Endemic Diseases For Farm-Animal Sustainability" programme (CEDFAS), the British Pig Executive (BPEX), and two industrial partners, Pfizer Ltd (UK) and BioBest - aims to identify why PMWS occurs and to develop new methods of controlling the disease.

One key-component of the project is the direct involvement of British pig farmers, thereby guaranteeing that pigs in Britain will be the first to benefit from this research, while collaboration with a major international pharmaceutical company will ensure that new veterinary products will be made available to pig farmers worldwide.

Now, two members of the team, Dr. Barbara Wieland and Pablo Alarcon-Lopez, a second year PhD student, have developed a novel approach to quantify severity of PMWS based on morbidity and mortality data and presence of porcine circovirus type 2 (PCV2). They applied factorial analyses, using data collected from 147 pig farms in England to identify variables contributing to variation in PMWS severity in a biologically meaningful way.

Together with other known variables linked to PMWS, the resulting factors were used to derive an algorithm for PMWS severity. The derived algorithm was used to develop a PMWS severity calculator, which now can be used by farmers directly to assess the PMWS severity on their own farm (http://www.bpex.org.uk/articles/300874).

The levels of PMWS severities identified on farm level can now be used to identify risk factors related to the different severity-categories, to assess the efficacy of PCV2 vaccination and to investigate the economic impact of potential control measures on a farm.

Medivet is celebrating its 100th batch collection for Vet Blood Supplies, the north London-based bloodbank set up in 2007 to provide blood products for its branches around the country.

Veterinary nurse Laura Brind, who is responsible for collecting the blood, said: "We are really proud to celebrate the 100th collection. We travel to Retired Greyhound Trust kennels across south-east England who kindly agreed to arrange the donation in return for free preventative treatment for the dogs."

The collection was taken from Barn Kennels, the Portsmouth branch of the Retired Greyhound Trust, which has been donating blood for the past 18 months.

Cat Professional is carrying out a survey to assess the use of Zylkène in cats with idiopathic cystitis (FIC), and is looking for owners whose cats are using the treatment to complete an online survey.

Zylkène is a nutritional supplement which has been reported to have positive effects in managing stress in cats and dogs. Zylkène is commonly used for reduction of stress in cats with FIC.

Veterinary practices that agree to help Cat Professional recruit clients whose FIC cats are receiving Zylkène will receive:

• A print copy of our book 'Caring for a cat with lower urinary tract disease' by Dr Sarah Caney and Professor Danièlle Gunn-Moore  
• A supply of flyers to hand out to owners eligible to participate in the survey. The flyer will explain the purpose of the survey and how owners can access it. In return for completing the survey, owners will receive a complimentary electronic copy of our book on FLUTD.

On completion of the survey, participants will receive a free electronic copy of the book 'Caring for a cat with lower urinary tract disease'.

For more information on the study, please visit our website: http://www.catprofessional.com.

The survey is accessible from the home page or directly at http://www.catprofessional.com/urinary-survey.html

Intervet/Schering-Plough Animal Health has produced a new medicine record book to help producers effectively document animal health product usage, to coincide with the cattle pneumonia season.

The Resflor-sponsored booklet incorporates space to record all the necessary information to comply with legislative requirements.

Intervet/Schering-Plough livestock veterinary adviser Paul Williams MRCVS said: "If you are in the business of rearing, producing or treating farm animals that will end up as food for human consumption, you must keep a record of any veterinary medicinal product you give or treat them with.

"You must also keep proof of purchase of all veterinary medicinal products and keep all your records for a period of five years. A format for keeping all these records is set out in this book."

To order Resflor medicine record books to give your clients, ring: 01694 731777

The Council of the Royal College of Veterinary Surgeons has approved a new Health Protocol, which formalises a more compassionate approach to veterinary surgeons with health problems.

The Protocol will allow - in appropriate circumstances - veterinary surgeons (and, from next year, registered veterinary nurses) who suffer from health concerns affecting their ability to practise safely, to have the matter dealt with confidentially, without going to a full public Disciplinary Committee hearing.

It will allow individuals to access appropriate support and help away from the public spotlight, while ensuring that they do not put animals or the public at risk.

According to independent legal advice sought by the College, such an approach is appropriate and necessary in order for the College to fulfil its regulatory responsibilities - similar systems exist within other regulators.

The draft Protocol was the subject of consultation amongst the profession and the public over summer. Proposed amendments to the RCVS Guide to Professional Conduct, to support the introduction of the Health Protocol, were also approved in the November meeting.

RCVS Head of Professional Conduct, Gordon Hockey said: "The Protocol encourages anyone coming into contact with veterinary surgeons - including other veterinary surgeons, veterinary nurses, members of practice staff, clients and healthcare professionals - who have concerns about a veterinary surgeon's health to report those concerns to the RCVS as soon as is reasonably practicable.

"Veterinary surgeons and veterinary nurses who are concerned about the health of a veterinary surgeon must also take steps to ensure that animals are not put at risk and that the interests of the public, including those of their colleagues, are protected."

HMRC has published advice concerning the forthcoming increase in the rate of VAT, from 17.5% to 20% on Tuesday 4th January 2011.

From 4th January, you will need to charge the new 20% VAT rate on all standard-rated sales you make and all retail takings your receive.

The new VAT fraction for the 20 per cent rate is 1/6 (used to calculate the VAT element of standard-rated gross takings).

If your business issues VAT invoices, you must use the new 20 per cent rate for all VAT invoices you issue on or after 4 January, which are issued within 14 days (or longer period that has been agreed with HMRC) of you providing the goods or services.

Supplies that span the rate change
If you supply goods or services before 4 January 2011, but issue a VAT invoice on or after that date, you can choose to charge VAT at 17.5 per cent.

Continuous supplies of services
For a contract that started before 4 January you can choose to charge the old rate, 17.5 per cent, on services actually performed before 4 January, and the new rate of 20 per cent on the value of services actually performed after.

Reclaiming VAT
From 4 January 2011, you may receive VAT invoices with the new 20 per cent rate, as well as VAT invoices with the old 17.5 per cent rate for goods or services you bought before the rate changed. In such cases, you should claim back VAT at the rate shown on the invoice.

Completing a VAT return
The deadlines for submitting VAT returns remain the same, so you should continue to submit VAT returns in the usual way - whether you send them monthly, quarterly or annually. For returns that span the change in rate, you will need to add together both the VAT on sales charged at 17.5 per cent and those charged at 20 per cent. You then put this total in box 1 of your VAT return.

Countering arrangements designed to take advantage of the VAT rate change
In order to counter businesses taking advantage of the VAT rate change by making arrangements that aim to apply the 17.5 per cent VAT rate to goods or services to be delivered or performed on or after 4 January 2011, anti-forestalling legislation has been introduced. Further details of this can be found in the web link below.

Further information
HMRC has published detailed guidance on the rate change, which can be found at www.businesslink.gov.uk/vatratechange/. 

Animalcare has launched Florgane, a novel, patented, long acting florfenicol 300mg/ml suspension which the company says has significant advantages over existing organic solvent-based florfenicol products on the market when used for the treatment and prevention of bovine respiratory disease (BRD).

Florgane is an aqueous, low viscosity advanced formulation, which, claims Animalcare, means that it is easier to inject even at temperatures as low as 5°C. Low temperature syringeability is important, as a large number of calves may need to be treated during colder weather at a time when the challenge from infectious agents is greatest. A syringeability study apparently demonstrated that Florgane is up to five times faster to administer when compared to the leading florfenicol non-aqueous formulation.

A paper on the treatment of naturally occurring respiratory disease with Florgane was presented recently at the British Cattle Veterinary Association (BCVA) Congress in Torquay. According to the company, the multi-centre field studies in Belgium, Germany and Italy, in over 400 cattle with bodyweights ranging between 73-180kg, demonstrated that Florgane given by a single intramuscular injection, at a 25% lower dose of 30mg/kg, is as efficacious as non-aqueous florfenicol 40mg/kg administered by subcutaneous injection, measured by treatment success and relapses.

Post mortem examination at day 27 (meat withdrawal of 37 days) confirmed that, despite being given via the intramuscular route, Florgane is well tolerated at the site of injection due to its aqueous base and physiological pH. Maximum volume per injection site is 15ml allowing calves up to 150kg to be treated.

Animalcare adds that a further advantage of Florgane is that it persists in plasma above the MICs for the three most common pathogens for significantly longer than conventional extended action 300mg/ml florfenicol solution preparations -  thereby prolonging bacterial killing time. Therefore, owing to its improved bioavailability and excellent pharmacokinetics, Florgane can be given at an easy to remember dose of 1ml per 10kg.

Tony Liepman, Marketing Manager at Animalcare said: "Using Florgane will result in faster administration, resulting in less stress for the calves and a saving in time and money for the farmer."

Florgane is presented in polypropylene 100ml and 250ml multi-dose vials with a three year shelf-life.

For more information, visit www.animalcare.co.uk

The British Veterinary Association has contacted the BBC programme 'Countryfile' following the broadcast of an item on identifying wild ponies in North Wales using 'ear marking' on 31st October 2010.

The programme visited a farmer in Snowdonia during the annual health check during which the wild ponies are brought into the town with support from the Countryside Council for Wales. During the programme presenter Jules Hudson asked the owner of the ponies, farmer Gareth Wyn Jones, how he can tell which pony is which. Gareth Wyn Jones explained that each pony has 'special ear marks' and there was footage of ponies with both ear tags and ear notches (marks or cuts). However, ear notching is no longer permitted under the Animal Welfare Act.

The BVA contacted Countryfile expressing concern at the programme's contents and asking for a clarification to be made. Countryfile responded to explain they were not aware of the law in relation to ear notching and tagging but that they would undertake to clarify the facts in a future programme.

The BVA has also been contacted by the pony welfare charity People4Ponies expressing concern about the ongoing practice of ear notching and tagging in England and Wales.

In light of the programme the BVA is asking its members to remind horse and pony-owning clients that ear tagging and ear notching are not permitted in Great Britain under the Animal Welfare Act as they do not appear in the list under Schedule 1 of the Mutilations (Permitted Procedures) Regulations 2007 (or under the Animal Health and Welfare [Scotland] Act).

Since July 2010 there has been a legal requirement that all horses and ponies are permanently identified by microchip (with some small exceptions) and the BVA believes this removes the need for any other form of identification, such as ear marking and hot branding, even for wild equids.

The BVA will also contact Local Government Regulation (the new name for LACORS - the Local Authorities Coordinators of Regulatory Services) and the Welsh Local Government Association to ensure that those with responsibility for policing animal health and welfare legislation in England and Wales are taking the appropriate action.

Harvey Locke, President of the British Veterinary Association, said:  "This is a simple fact of legality and it appears there was widespread ignorance of the rules amongst all those taking part in the programme.

"As veterinary surgeons we have a responsibility to work with clients to ensure they are complying with animal health and welfare legislation. Ear mutilations are not permitted and we must make sure that message is reaching horse and pony owners.

"The BVA will also be contacting those responsible for enforcing the legislation relating to ear mutilations in horses and ponies to make sure the law is being policed."

The Disciplinary Committee of the Royal College of Veterinary Surgeons has postponed judgment on sanction for 12 months in the case of a Hampshire veterinary surgeon found guilty of serious professional misconduct for cumulative failures to provide adequate professional care, and insufficient regard for animal welfare whilst treating a dog.

At a hearing which concluded last Thursday, Peter Ardle MacMahon MRCVS faced a six-part charge after working as a locum for Vets Now at North End in Portsmouth where, on the night of 14/15 July 2009, he treated Wilfred, a Cocker Spaniel who had ingested broken glass along with raw mince. 

The Committee found that, having decided that surgery was an appropriate treatment, Mr MacMahon had not removed the glass identified on a radiograph. Nor had he even superficially searched the stomach contents he had evacuated to check that a large piece of glass he had previously identified on the radiograph had been removed. He had also not taken adequate steps to prevent contamination of Wilfred's abdominal cavity prior to the incision to the stomach.

Mr MacMahon admitted he knew there had been considerable spillage of stomach contents into Wilfred's abdomen. The Committee found that, with this knowledge, for Mr MacMahon to use only 250ml of fluid to lavage the abdomen was inadequate. This contributed to the Spaniel developing chemical peritonitis which might have developed into septic peritonitis but for a second operation the next morning, after the dog had been returned to the care of his usual veterinary practice. The Committee also expressed concern that Mr MacMahon had failed to effectively communicate the abdominal contamination to Wilfred's usual vets when he was handed back into their care. 

Taken as individual allegations, these would not, in the opinion of the Committee, constitute serious professional misconduct. However, the Committee was of the view that, taken cumulatively, the charges were proved, and therefore the treatment given to Wilfred, fell far short of the standard to be expected in the profession.

When considering mitigating and aggravating factors, the Committee accepted that Mr MacMahon and the veterinary nurse assisting him were unfamiliar with the premises in which they were working, resulting in a difficulty in locating important equipment, and there were also multiple urgent cases during the evening the operation took place. The Committee also noted that 17 months had passed since the operation, and no further complaints against Mr MacMahon had been received by the RCVS.

The Committee further took into account that Mr MacMahon had little recent experience, having returned to practising veterinary medicine in January 2009, following almost ten years spent outside the veterinary profession. During this hiatus he undertook no continuing professional development (CPD), and completed only a five-week period of supervised practice prior to re-entering the profession. 

Mrs Caroline Freedman, Chairman of the Disciplinary Committee said: "The Respondent placed himself in this situation: he knew that he had been out of practice for ten years, had not done any formal CPD during that time and chose to accept an appointment to work as a locum in a sole-charge out-of-hours emergency clinic. A foremost aggravating factor is that animal welfare was adversely affected. A non-critical patient was placed at risk by the Respondent's failures."

The Committee reiterated that the purpose of sanctions was not to be punitive, but to protect animal welfare, to maintain public confidence in the profession and to maintain professional standards.  "A postponement of judgment, with suitable undertakings from the Respondent, is the correct course of action," said Mrs Freedman. Mr MacMahon has subsequently signed undertakings relating to CPD in both surgical and medical disciplines, and the Committee has postponed for 12 months its judgment as to any further sanction.

Pfizer Animal Health is advising vets and horse owners to be on guard against the threat of West Nile Virus (WNV) in the UK, following a spate of outbreaks of the disease in several European countries this year.

West Nile Virus has recently made headline news because of a human outbreak in Greece which resulted in a number of deaths. Outbreaks have also occurred in Russia, Romania and Italy during 2010. West Nile Fever is a viral disease transmitted by mosquitoes, which carry the virus after biting infected birds. Primarily occurring between July and October, in line with typical peak activity of mosquitoes, it can have serious consequences on human and equine health, with severe cases resulting in fatal neurological disease.

There is no cure, though supportive treatment can aid recovery. However if the disease progresses to a state where the animal is not able to stand up, their chance of survival is considered low. Prevention of infection is difficult, but any steps that reduce mosquito numbers or the likelihood of horses and people being bitten may help to reduce the risk in areas where the disease is present. However, the only way to reduce the risk of an individual horse developing disease due to WNV is through vaccination.

Ben Gaskell, Pfizer's equine veterinary advisor said: "West Nile Virus may well become a very real threat to both horses and humans in Northern Europe. It is important for vets, horse owners and infectious disease experts to work together to mitigate its impact in the event of the virus becoming endemic across Europe. The rapid spread of the disease across North America is an illustration of what could potentially happen in Europe and it is important to remember there is no curative treatment - the only way to prevent clinical disease in horses is by vaccination." 

Pfizer Animal Health supports the PrEquID (Prevention of Equine Infectious Disease) group, which consists of internationally recognised equine and infectious disease experts. The group was formed to develop guidelines on the prevention and control of a number of equine infectious diseases, on a global basis. 

Klaus Osterrieder, Professor and Chair in the Institut für Virologie in the Veterinärfakultät at Freie Universität Berlin, Germany and a member of the PrEquID group advises: "Horse owners should ask their veterinarian for advice on appropriate prevention measures.  Experience has shown that adopting a prudent prevention strategy can be a very effective way of managing this devastating disease."

Further information on WNV is available at www.westnile.eu.

Intervet/Schering-Plough Animal Health is now supplying Cepravin dry cow antibiotic treatment in a new 'flexi-cap' tube which offers two ways of infusing the product into the cows' teats.

According to the company, the new cap is easier to remove and can be quickly flicked off with a fingernail, whilst the shorter, thinner nozzle option may reduce the chances of damaging the teat canal and teat end. Farmers can be assured that administering Cepravin dry cow therapy with a shorter, thinner nozzle still delivers the antibiotic where it needs to be, and at the correct dose.

Jennifer O'Connor, vet adviser at Intervet/Schering-Plough Animal Health said: "The teat canal is a vital barrier to infection. A gentle infusion technique is essential to avoid causing damage, reducing its ability to close properly and form a keratin plug to help keep infection out. We are delighted to be introducing an innovative development for one of the UK's most widely used dry cow tubes."

The Veterinary Karting Championship, organised by NVS, is proving a huge success, according to the company. At the half way stage of the championship, around two hundred drivers have already participated in regional events in Manchester, Edinburgh, Essex, Surrey and Reading. 

Drivers arrive following evening surgery and change from veterinary uniforms into their race suits. All drivers receive race and safety briefings before heading off to meet their team mates and get a feel for the track during the practise session.

Racing lasts for an hour and a half, during which time teams have to use clever strategies and tactics to remain in pole position and avoid eviction from the track for foul play.  At the end of the evening, all competitors get a goody bag and jacket, with each member of the winning team receiving a bottle of champagne, a trophy and certificate. 

Caitrina Harrison, Sales & Marketing Director at National Veterinary Services, said: "All the evenings have been great fun and have certainly shown the competitive side of the veterinary profession.  The ladies have definitely given the men a run for their money, especially in Scotland.  Some drivers have been so inspired by the events that they are looking to host their own inter-practice championships next year."    

The teams that have qualified so far for the National Final are: Manchester Bears, Essex Panthers, Scottish Bears (pictured), Reading Bears and Camberley Elks. There will be a break from racing over the festive period, with the next regional heat taking place in Bristol on Tuesday 18^th January.  Further heats will then be held in Birmingham, Loughborough, Aylesbury and Leeds, followed by the National Final on Sunday 20^thMarch in Milton Keynes.

Caitrina Harrison continues: "NVS would like to thank the event sponsors for their support, which has been invaluable in making the championship happen.  The championship sponsors are Agria Pet Insurance, Hill's Pet Nutrition, Dechra

Dechra Pharmaceuticals PLC has announced that it has acquired the entire issued share capital of Genitrix Limited ("Genitrix") from its owner managers for an initial cash consideration of £5.4 million, with a further £0.8 million being payable upon achievement of specific milestones.

Dechra says the acquisition of Genitrix is consistent with its strategy to grow its international veterinary pharmaceutical business. In the year ended 31 March 2010, Genitrix achieved revenues of £2.4 million.

Ian Page, Chief Executive of Dechra, said: "Genitrix range of equine and companion animal products enhances and complements our UK product portfolio.  Furthermore the recently approved canine epilepsy product, Libromide, provides future growth opportunities through potential mutual recognition in Europe.  The acquisition is expected to be earnings enhancing in the first full year following ownership."